Steven Copenhaver, M.D.

Associate Professor

School Medical School

Department Pediatrics

You have reached the Academic Profile.

For more information on the doctor and patient care, please visit the clinical profile.

View Clinical Profile

Medical School: Texas A & M University College of Medicine (1989)
Internship: Duke University Medical Center (1990), Pediatrics
Residency: Duke University Medical Center (1992), Pediatrics
Fellowship: University of Colorado Health Sciences Center (1996), Pediatric Pulmonology

Featured Publications

Forced Expiratory Volume in 1 Second Variability Helps Identify Patients with Cystic Fibrosis at Risk of Greater Loss of Lung Function.: Morgan WJ, VanDevanter DR, Pasta DJ, Foreman AJ, Wagener JS, Konstan MW J. Pediatr. 2016 Feb 169 116-21.e2
Beclomethasone diproprionate reduced airway inflammation without adrenal suppression in young children with cystic fibrosis: a pilot study.: Wojtczak HA, Kerby GS, Wagener JS, Copenhaver SC, Gotlin RW, Riches DW, Accurso FJ Pediatr. Pulmonol. 2001 Oct 32 4 293-302
Cystic Fibrosis: a case of "faded genes": Browne BA, Brunner LJ, Weir MR, Copenhaver, SC Journal of Clinical Problem Based Learning 2000 May
Early inflammation and the development of pulmonary disease in cystic fibrosis.: Wagener JS, Kahn TZ, Copenhaver SC, Accurso FJ Pediatr Pulmonol Suppl 1997 16 267-8
Increased DNA levels in bronchoalveolar lavage fluid obtained from infants with cystic fibrosis.: Kirchner KK, Wagener JS, Khan TZ, Copenhaver SC, Accurso FJ Am. J. Respir. Crit. Care Med. 1996 Nov 154 5 1426-9